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T he integrin LFA-1 (lymphocyte function-associated antigen 1) plays a critical role in lymphocyte recirculation, diapedesis, and regulation of immune responses (1, 2) . A remarkable property of LFA-1 is the large dynamic range of adhesion strength that is observed commensurate with the physiological context. LFA-1 participates in slowing rolling interactions (3) (4) (5) , which requires rapid bond formation and rupture. LFA-1, however, is most important in mediating fluid shear-resistant firm adhesion and cell migration (1, 6, 7) and in maintaining the integrity of the immunological synapse, which requires stable, less labile bonds (8) .
The adhesion of LFA-1 to ligands on opposed cell surfaces is controlled by the combination of two distinct mechanisms: an increase in the affinity of individual receptors to bind ligand (affinity modulation) and an increase in the total number of bonds formed (valency modulation) (9) (10) (11) (12) (13) (14) (15) (16) . Affinity of LFA-1 is regulated by conformational changes of individual monovalent receptors, whereas valency is regulated by the lateral mobility and clustering of receptors that change the number of bonds engaged at the contact area.
In the complex environment of the cell, affinity and valency modulation are potentially cooperative, and it is difficult to dissect the roles of the two mechanisms in mediating stable adhesion and migration. For example, whereas stimulation by chemoattractants or T cell receptor cross-linking is known to enhance adhesion of LFA-1-expressing cells to intercellular adhesion molecule 1 (ICAM-1) substrates (11) , which enables rapid arrest of flowing leukocytes on endothelial cells (16, 17) , direct affinity up-regulation stimulated by receptor tyrosine kinases or G protein-coupled receptors has not been demonstrated. This problem stems from a lack of reagents that are suitable for detecting affinity modulation of LFA-1 on the cell surface, where affinity up-regulation must be determined by binding of soluble monovalent ligands (9, 10, 12) . Even in the high-affinity (HA) conformation, the binding of soluble monovalent ICAM-1, the strongest LFA-1 ligand identified (18) , is weak and barely detectable (13, 15, 19) . In lieu of direct detection of binding of monovalent ICAM-1, surrogate approaches have been adopted for detecting distinct activation states of LFA-1. Lollo et al. (15) used an indirect measurement, the displacement by soluble ICAM-1 of 125 I-labeled Fab fragment, to estimate the affinity increase upon activation with phorbol myristoyl acetate (PMA). The binding of bivalent and multivalent ICAM-1 also allows one to assess increased affinity after activation (13, 16) ; however, with use of these reagents, complete separation of the affinity and valency states is not obtained.
The use of mAbs that bind selectively to the active conformation of LFA-1 represents an alternative, if indirect, approach for studying affinity up-regulation on the cell surface. Activation-dependent LFA-1 mAbs reported thus far map outside of the ligand-binding inserted (I) domain: NKI-L16 (20, 21) maps to the genu of the ␣ L subunit, m24 (22) (23) (24) and 327C (25) bind to the ␤ 2 I-like domain, and KIM127 (26, 27) maps to I-EGF domain 2 in the ␤ 2 leg. Integrins that lack I domains have been shown to exist in at least three conformational states: bent (low affinity), extended with a closed headpiece putative intermediate affinity, and extended with an open headpiece (high affinity) (28, 29) . Thus, extension, which is sufficient for exposure of the leg epitopes, coexists with two distinct conformations of the ligand-binding headpiece. Because affinity of LFA-1 is enhanced by conformational changes of the I domain (18, 30, 31) , activation-dependent mAbs that map outside of the ligand-binding I domain cannot be used to ascertain LFA-1 affinity. Here, we functionally characterize a mAb, AL-57 (activated LFA-1 clone 57), that was selected by phage display for reactivity with the isolated ␣ L I domain mutationally stabilized in the open, HA conformation. We demonstrate that binding of AL-57 is extremely sensitive to LFA-1 activation and can discriminate between low-affinity, intermediate-affinity (IA), and HA states of the integrin. We use this ligand-mimetic property of AL-57 to conclusively demonstrate affinity up-regulation of LFA-1 in lymphocytes stimulated by chemokine.
Results
Surface Plasmon Resonance (SPR) Analysis. Selection of a human Fab library by phage display and identification of AL-57 is described in detail in ref. 32 . We studied binding kinetics and selectivity of AL-57 for alternative conformations of the ␣ L I domain by using SPR. For comparison, we used MHM24, a conventional activation-insensitive mAb to the ␣ L I domain. MHM24 is a mouse mAb to human LFA-1 (33) that was humanized as efalizumab (Raptiva) and is used for the treatment of psoriasis patients (34) (35) (36) . To exclude bivalent interactions, mAbs were immobilized on CM-5 sensor chips, and monovalent I domains were injected as analytes. MHM24 showed comparable binding and dissociation constants (K D ) to WT disulfidelocked, IA L161C͞F299C and HA K287C͞K297C mutant I domains (31) (Fig. 1A and Most ligands to integrins, including ICAM-1, use an acidic residue to directly coordinate a magnesium ion at the metal ion-dependent adhesion site of the integrin I domain (31, 37, 38) . The ligand-mimetic properties of the AL-57͞LFA-1 interaction, especially the Mg 2ϩ dependence of binding, led us to hypothesize that an interaction with an acidic residue in AL-57 is also required for I domain binding. The sequence of the complementarity-determining regions (CDRs) of the light and heavy chains revealed only three acidic residues: one Asp residue in CDR2-H and two Asp residues in CDR3-H ( Fig. 2A) , which we mutated individually to alanine.
Binding of parental and mutant AL-57 IgG to an isolated HA mutant I domain expressed on the surface of K562 cells (39) was tested by using immunofluorescent flow cytometry (Fig. 2B) . Parental AL-57 bound well to the HA I domain in the presence of Mg 2ϩ . Binding of parental AL-57 was abolished by EDTA, confirming Mg 2ϩ -dependent binding (Fig. 2B , open histograms). Although the mutations D62A and D108A had no effect, the mutation D101A in heavy chain CDR3 completely abolished binding to the HA I domain (Fig. 2B ). This result further supports the ligand-mimetic nature of recognition by AL-57 of the ␣ L I domain.
Binding to WT ␣L␤2 Activated by Agonists. Binding of AL-57 to WT ␣ L ␤ 2 was examined by using WT LFA-1 on K562 transfectants as well as endogenously expressed LFA-1 on human T lymphocytes. In either context, LFA-1 activation, either with Mg 2ϩ ͞ EGTA or Mn 2ϩ , was required to observe significant AL-57 binding (Fig. 3) .
Chemokine Activation. AL-57 was used to observe LFA-1 activation after treatment with CXCL-12 (SDF-1) or the protein kinase C activator PMA. To exclude avidity (valency) effects, we used monovalent AL-57 Fab as the detection reagent. To obtain a large dynamic range of AL-57-detected activation, we used IL-15-cultured primary T cells. In mice (40) SPR analysis was performed by using a BIAcore 3000 instrument. The I domains (IA, L161C͞F299C mutant; HA, K287C͞K294C mutant) were perfused onto antibodies immobilized on a CM-5 chip in buffer containing 1 mM Mg 2ϩ or 10 mM EDTA at a flow rate of 20 l͞min at room temperature. The data were fit by using a parallel reactions model plus drift to account for baseline offset, and K D was calculated as koff͞kon. Data are means Ϯ SEM of at least three independent experiments. ND, binding not detected. *Determined by steady-state analysis.
activity, whereas culture in IL-2 induces effector cells that express activated LFA-1 with increased basal ICAM-1 binding. The conformation-sensitive Ab KIM127 that maps to the leg of the ␤ 2 subunit (27, 41) was used to correlate global conformational rearrangement of LFA-1 with stimulation; the activationinsensitive Ab TS2͞4 was used to quantify the total expression of LFA-1 on the cell surface.
We measured Ab epitope site density by using beads containing known numbers of mouse IgG-binding sites as described in Methods. In the resting condition, primary T cells cultured in IL-15 had a total of 27,000 LFA-1 sites per cell as determined with the conformation-insensitive mAb TS2͞4. Resting T cells showed few AL-57-and KIM127-binding sites (Table 2) . Upon stimulation with PMA or the chemokine CXCL-12 (SDF-1), the total number of LFA-1 sites increased slightly to 34,000 sites per cell ( Table 2) . By contrast, the number of AL-57 and KIM127 sites increased 10-fold or more, from 200-300 sites on resting cells to 2,200-3,900 sites on PMA-and CXCL-12-stimulated cells (Table 2 ). These results demonstrated that AL-57 could detect affinity up-regulation of LFA-1 by stimulation of both protein kinase C and a G protein-coupled receptor. In addition, the results showed that AL-57 and KIM127 activationdependent neoepitopes are expressed on subpopulations of Ϸ10% of the LFA-1 molecules on the surface of agoniststimulated T cells. Furthermore, AL-57 site density and KIM127 site density are roughly the same on agonist-stimulated T cells.
The adhesiveness of LFA-1 stimulated by the T cell receptor and G protein-coupled receptors has been shown to be transient (11, 16, 42) . We therefore used AL-57 Fab to examine the kinetics of the increase in LFA-1 affinity after stimulation with CXCL-12. By the 2-min time point (the earliest time observable in our assay), AL-57 binding was significantly increased (Fig. 4) . Binding peaked within 2-5 min after stimulation and was unobservable after 10 min.
Discussion
We demonstrate that the human mAb AL-57 specifically recognizes the active conformation of the LFA-1 I domain and use AL-57 to characterize the affinity state of LFA-1 on activated lymphocytes. Several lines of evidence demonstrate that AL-57 mimics ligands of LFA-1, such as ICAM-1. First, AL-57 binds to None 200 Ϯ 100 300 Ϯ 100 27,000 Ϯ 3,300 PMA 3,900 Ϯ 1,300* 2,800 Ϯ 700* 34,000 Ϯ 3,800 CXCL- 12 2,200 Ϯ 800* 3,300 Ϯ 500* 34,000 Ϯ 3,800
Human T lymphocytes were stimulated with PMA (100 nM) or CXCL-12 (SDF-1, 100 ng͞ml) for 20 min at 37°C in the continued presence of antibody. Binding sites were determined with FITC anti-light chain and AL-57 Fab or FITC-KIM127 and FITC-TS2͞4 IgG, and standardization was performed with beads containing known numbers of mouse IgG-binding sites as described in Methods. Data are the average of at least three independent experiments Ϯ SEM. * , P Ͻ 0.05 vs. no stimulation.
LFA-1 in an activation-dependent manner: This mAb binds to LFA-1 on the cell surface only when LFA-1 is activated; the affinity of AL-57 progressively increases as the affinity of the LFA-1 I domain for ICAM-1 rises, and binding of AL-57 to the low-affinity I domain is undetectable. Second, formation of the AL-57͞I domain complex is Mg 2ϩ -dependent. Third, an aspartic acid residue in CDR3 of the heavy chain is required for binding. This residue is hypothesized to be responsible for the Mg 2ϩ -dependent binding through a direct coordination to the metal ion-dependent adhesion site metal. The interaction between an acidic residue in the ligand and the I domain-bound metal is a characteristic feature of authentic integrin-ligand architecture (31, 38, 43 Compared with ICAM-1, AL-57 has comparable affinity for the mutant IA I domain and seven times higher affinity for the mutant HA I domain (Table 3) . Furthermore, compared with ICAM-1, the k off of AL-57 is 8 times slower for the IA I domain and 250 times slower for the HA I domain ( Table 3 ). The greater stability of the Ab-receptor complex compared with the ligandreceptor complex makes AL-57 an excellent reagent for investigating affinity up-regulation of LFA-1, as demonstrated here on chemokine and PMA-stimulated lymphocytes. The slow k off of AL-57 enhances its ability to probe affinity up-regulation when used for immunostaining of cells, in which dissociation of probes during washing hampers sensitive detection.
The ligand-mimetic feature of AL-57 is unique among several activation-dependent mAbs to integrin I domains that have been described. A function-blocking and activation-dependent mAb to the Mac-1 I domain, CBRM1͞5 (45) , maps adjacent to, rather than on, the ligand-binding site and does not require divalent cations (46) . An ␣ 2 I domain mAb, IAC-1, binds preferentially to the active form but does not compete with ligand (47) . A function-blocking mAb 107 binds to the Mac-1 I domain in a divalent cation-dependent manner but favors the closed conformation (48) . An ␣ 1 I domain mAb, AQC2, is not activationdependent yet is revealed by a crystal structure to coordinate to the metal ion-dependent adhesion site (MIDAS) through an Asp residue in CDR3 of the heavy chain (49) . In contrast to AL-57, binding of AQC2 is decreased but not abolished in the absence of a metal or by Ala substitution of the MIDAS metalcoordinating Asp residue in CDR3 (49) .
Activation-dependent Abs have been used to establish the structural mechanism of LFA-1 activation (20-22, 25, 27, 41, 44, 50) . For example, the epitope of mAb KIM127 used in this study maps to a ␤ 2 leg epitope that is shielded in the bent, resting integrin conformation and becomes exposed in the extended, activated state (27, 28, 41, 51) . The extended LFA-1 can contain a low-affinity, IA, or HA I domain, depending on the strength of activation and the density of ligand (9, 52) . Therefore, the ability of AL-57 to directly report I domain conformation allows us to define LFA-1 conformations more precisely. The specificity of AL-57 for ligand-unoccupied LFA-1 further distinguishes it from previously available activation-dependent mAbs to LFA-1 described above, which bind whether or not LFA-1 is bound to ligand. Because affinity of AL-57 to the disulfide-locked HA I domain is 200 times higher than affinity to the disulfide-locked Binding kinetics to the alternative conformations of the ␣L I domain (IA, L161C͞F299C mutant; HA, K287C͞K294C mutant) was measured by SPR with a BIAcore instrument in the presence of 1 mM MgCl 2. *For binding to the IA I domain, k on and koff were obtained by curve-fitting using a 1:1 binding model. KD was calculated by a Scatchard plot using binding at steady state. For binding to the HA I domain, k on and koff were obtained by using a parallel reactions model plus drift to account for baseline offset, and K D was calculated by koff͞kon. Data are means Ϯ SEM of at least three independent experiments. ND, binding not detected. † Data are from ref. 31 .
IA I domain, AL-57 would detect HA LFA-1 more efficiently than IA LFA-1 on the cell surface. However, one needs to consider the possibility that, with WT LFA-1 on live cells, AL-57 binds to both IA and HA conformations of LFA-1.
We have demonstrated by using Fab AL-57 that LFA-1 on lymphocytes increases its affinity upon activation of protein kinase C with PMA and physiological stimulation of G proteincoupled receptor CXCR4 with the chemokine CXCL-12. We have also shown that only a subset of Ϸ10% of the total number of LFA-1 molecules on T cells shows affinity up-regulation after stimulation with PMA and CXCL-12. These results with AL-57 Fab to LFA-1 on T cells correlate well with previous results with CBRM1͞5 Fab to Mac-1 on neutrophils (45) . Whereas neutrophils barely express CBRM1͞5-binding sites in the resting condition, stimulation with PMA and the chemoattractant f-MetLeu-Phe induced expression of the CBRM1͞5 epitope on 10-30% of cell surface Mac-1 molecules. Both CBRM1͞5 and AL-57 completely block ligand binding. Thus, after physiologic activation, a small subset of Mac-1 molecules on neutrophils and LFA-1 molecules on lymphocytes becomes competent to mediate adhesion.
The active, extended conformation of LFA-1 probed by KIM127 also represents a subset of Ϸ10% of the total LFA-1 molecules on activated T cells. Interestingly, the number of AL-57-binding sites is approximately equal to the number of KIM127-binding sites. This result strongly suggests that affinity up-regulation by chemokine as measured with AL-57 coincides with receptor extension as measured by KIM127. These results are consistent with electron microscopy and crystal structure studies on integrins that show that extension is essential for hybrid domain swing-out, which is allosterically linked to conversion of the ligand-binding site to the HA state (28, 29) .
We used AL-57 Fab to study the kinetics and mechanism of LFA-1 activation after stimulation with CXCL-12. A transient increase in LFA-1 activity has been shown to be induced by chemokines through G protein-coupled receptor signals (16, 42, 53) and T cell receptor cross-linking (11) . Although a rapid and reversible increase in affinity by dynamic conformational change of LFA-1 has been proposed, it has not been possible previously to measure monovalent affinity separately from multivalent avidity. Previous studies have measured adhesion to ICAM-1 immobilized on substrates (11, 42, 53) , binding of multivalent protein micelles of full-length ICAM-1 (16), or competition with Fab binding (15) to overcome the inherently weak binding of ligand. Previous studies have reported that adhesiveness or multivalent ligand binding peaked at 2 min (16) or 10 min (53) after G protein-coupled receptor stimulation or 10 min after T cell receptor stimulation (11) . Using ligand-mimetic AL-57 Fab, we unambiguously measured an increase in monomeric affinity of LFA-1 that was transient and peaked at 2-5 min after chemokine stimulation. The similarities in the kinetics of up-and down-regulation of monomeric affinity and adhesiveness suggests that affinity up-regulation is the dominant factor in T cell receptor-induced and G protein-coupled receptor-induced, transient, LFA-1-mediated adhesiveness.
Methods
Abs. Details of selection of a human Fab library by phage display are described elsewhere (32) . Briefly, the library was positively selected with the disulfide-locked HA K287C͞K294C mutant I domain and negatively selected with the WT low-affinity I domain (31) . Phage clones expressing Fab fragments were examined for preferential binding to the locked HA I domain over the disulfide-locked, low-affinity L289C͞K294C mutant I domain (31) . We found that clone 57 selectively recognized the HA I domain, and we designated it ''AL-57'' for activated LFA-1 clone 57. For further characterization, a Fab format of clone 57 was converted to an intact human IgG1 format. AL-57 IgG1 was expressed in CHO cells and purified with a protein L affinity column, followed by gel filtration on a Superdex 200 column (Amersham Pharmacia, Piscataway, NJ). AL-57 Fab and control Fab (from human IgG1; Calbiochem, San Diego, CA) were generated by papain digestion with a Fab preparation kit (Pierce, Rockford, IL) and further purified on a MonoQ HR 5͞5 ion exchange column (Amersham Pharmacia). For studying interactions of acidic residues of AL-57 with the I domain, three Asp residues in CDRs were individually mutated to alanine by using the QuikChange mutagenesis kit (Stratagene, La Jolla, CA). Parental and mutant AL-57 IgGs were expressed in 293T cells.
SPR. SPR analysis was performed by using a BIAcore 3000 instrument (BIAcore, Uppsala, Sweden). Abs were immobilized on a CM-5 sensor chip as described in ref. 54 . WT locked intermediate and open I domains were as described in ref. 44 . SPR measurements were performed in 10 mM Tris⅐HCl (pH 7.4)͞140 mM NaCl͞1 mM MgCl 2 ͞0.005% Tween 20 at a flow rate of 20 l͞min. The data were fit by using a parallel reactions model plus drift to account for baseline offset. The second binding constant was at least one order of magnitude weaker.
Cells. K562 transfectants that express WT LFA-1 are described in refs. 23 and 39. Peripheral blood mononuclear cells were generated by centrifuging fresh blood through Histopaque (Sigma, St. Louis, MO) and taking the buffy coat. Lymphocytes were prepared by adsorbing the monocytes to gelatin-coated plates and culturing nonadherent lymphocytes in RPMI medium 1640 supplemented with 10% FBS and phytohemagglutinin (1 g͞ml) for 
